BioMedNewsBreaks – Silo Pharma Inc. (SILO) Produces First Batch of SPU-21 Liposomes for RA Study
Apr 20, 2022
Silo Pharma (OTCQB: SILO) is a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic. The company today announced that it has produced its first batch of liposomes for use in a preclinical study that will be conducted by Frontage Laboratories, a CRO (contract research organization). According to the update, the ability of the SPU-21 to target inflamed epithelium suggest their potential use to target drug delivery. Silo’s novel joint homing peptides can be used to treat autoimmune diseases, which include but are not limited to rheumatoid arthritis (“RA”). This approach could enhance the therapeutic effect of current and future therapies and decrease potential toxicity. SPU-21 has potential for the development of fusion imaging molecules and/or nanoparticles to study arthritic pathogenesis. “The production and delivery of liposomes for our upcoming study with Frontage advances SPU-21 and allows us to further study anti-arthritic activity in animals,” Eric Weisblum, CEO of Silo Pharma, said in the press release. “We look forward to sharing the results of the study upon completion and data collection.”
To view the full press release, visit https://ibn.fm/49yQR
About Silo Pharma Inc.
Silo Pharma is a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s, Parkinson’s and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research, which the company believes will be transformative to the well-being of patients and the health care industry. For more information about the company, visit www.SiloPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Qantas’s New York-to-Sydney ‘Project Sunrise’ Flights to Take Off in 2028
Qantas Airways said the 18-hour flights, part of its Project Sunrise program, would come months after its 22-hour direct flights from Sydney to London begin.
How can tensions ease for China-US trade?
The U.S.-initiated trade war against China and most other global trading partners has eased since President Donald Trump imposed his so-called "liberation day" tariffs back in April 2025.
Billy Bush Joins Fox News a Decade After ‘Access Hollywood’ Tape Scandal
He lost his job as a “Today” show anchor in 2016 after footage surfaced of Donald J. Trump joking with him about sexual assault. He will be a Fox contributor.
New EU industry rules would damage UK, warns Burnham
The prime minister met the European Commission President during his visit to the United Nations General Assembly.
Trump Says He Supports Banning Diesel Exports to Bring Down Prices
Diesel prices have been setting records because of the war in Iran, but the oil industry say banning U.S. exports would not make the fuel cheaper.
Trump says he would back ban on diesel exports
Republicans lawmakers have put pressure on the president to curb exports as diesel prices soar to record highs in the US.
Business Daily
Jacob Rothman built a manufacturing business in China supplying major retailers
How Paramount Won Warner Bros.
After months of legal and political wrangling, the media mogul David Ellison arrived at a deal with the coalition of states seeking to block his $111 billion acquisition of Warner Bros. Discovery.
Global Oil Price Drops Below $100 a Barrel
Investors anticipated that a damaged Saudi Arabian pipeline may be close to reopening, allowing more oil from the region to reach world markets.
The A.I. Party House Where Networking Has a Dark Side
Group tech houses have proliferated across the San Francisco Bay Area in the artificial intelligence boom. One of the most prominent has also racked up an extensive police record.
Rosie O’Donnell Says ABC Delayed a Skit as It Readied Trump Suit
The network asked the comedian to hold off on the sketch, which mocked the president, when she filled in as host of “Jimmy Kimmel Live!”
An A.I. Image of Trump Kissing a Woman Was Fake. It Spread Anyway.
Advances in artificial intelligence and the myriad ways content is shared online have made establishing authenticity even more difficult for users of social media.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.